Press release content from Business Wire. The AP news staff was not involved in its creation.
Genetron Health Presented Its Proprietary Early Screening Technology Mutation Capsule at Science/AAAS Webinar
April 1, 2021 GMT
Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH) sponsored a
Science /AAAS Webinar, “Early cancer screening today and tomorrow: Exploring liquid biopsy profiling for diagnosis and treatment”, which launched today.
During the panel discussion, Genetron Health’s Chief Technology Officer, Dr. Yuchen Jiao, gave a speech entitled “Profiling cfDNA-based Biomarkers for the Early Detection of Cancer”. In his presentation, Dr. Jiao highlighted the importance of early detection as the most effective method to prevent deaths from cancer.